JONATHAN D. ADAMS, PHARM, D.; JAMES P. WILSON, PHARM, D.
ADAMS J., WILSON J.; Correction: Dactinomycin Dose. Ann Intern Med. 1983;98:262-263. doi: 10.7326/0003-4819-98-2-262_3
Download citation file:
Published: Ann Intern Med. 1983;98(2):262-263.
To the editors: in the letter from pandya and chang (1) the dose of dactinomycin was given as 10 mg/m2 body surface area. It appears that this dose is in error. An article (2) cited by Pandya and Chang reported an Einhorn-type regimen and did not use dactinomycin. Most VAB (vinblastine, dactinomycin, and bleomycin) regimens (3-5), as the authors' appears to be, use a dactinomycin dose of 1 mg/m2 body surface area. We suggest that a decimal point is missing, and that anyone interested in using the authors' regimen carefully review this dose.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only